Penn's 'Enhanced Recovery' program significantly reduces post-op opioid use

August 06, 2020

PHILADELPHIA--The majority of patients who followed an "Enhanced Recovery After Surgery" (ERAS) protocol did not need opioids for pain management at multiple time points following elective spinal and peripheral nerve surgery. The findings come from an expanded analysis and study from researchers in the Perelman School of Medicine at the University of Pennsylvania, published in Pain Medicine. Researchers found that when an ERAS protocol was employed--which optimizes patients' surgical care before, during, and after surgery--fewer patients needed pain medications at one, three, and six months after surgery.

The ERAS protocol developed at Penn includes a personalized, safe, and effective pain management plan to help prevent opioid addiction, which is an ongoing public health crisis in the United States. ERAS engages patients in their care before, during, and after their hospitalization--this process includes patient education, text reminders, nutrition information, early mobilization, and recovery plans. ERAS also relies on collaborative care between all individuals involved in the patient's surgical journey, including anesthesiologists, rehabilitation therapists, nurses, and neurosurgeons, to improve clinical outcomes and optimize a safe recovery.

"We know from our clinical experience and previous literature that programs like ERAS work, but we didn't expect the impact on opioid use to be so sizeable," said senior author Zarina S., Ali, MD, an assistant professor of Neurosurgery at Penn. "The most important outcome from this study is the decrease in opioid use. Furthermore, patients following the ERAS protocol reported less opioid use without higher pain scores. This represents an important advance in the context of the current nationwide opioid epidemic."

For this study, a total of 1,141 patients were enrolled in the ERAS protocol, compared to 149 historical controls who received the standard of care. Both groups had similar surgical procedures and demographics. Preliminary findings summarizing opioid use after one month of the ERAS protocol were published in the Journal of Neurosurgery: Spine in 2019. This Pain Medicine paper reports on continued benefits over an 18-month period utilizing the ERAS pathway in elective spinal and peripheral nerve surgery.

The researchers found a significant reduction in use of opioids by following the ERAS protocol at one, three, and six months following surgery--only 38.6 percent of those following ERAS needed pain medications one month after surgery, whereas 70.5 percent of the control group needed pain medications at one-month post-op. At three months after surgery, 36.5 percent in the ERAS cohort needed pain medication, compared to 70.9 percent of the controls, and six months after surgery only 23.6 percent of patients following the ERAS protocol needed pain medication, compared to 51.9 percent in the control group.

In addition to the significant reduction of opioid use, use of patient-controlled analgesia (PCA)--known as a pain pump--was nearly eliminated in the ERAS group (1.4 percent) compared to 61.6 percent of patients in the control group. ERAS patients were up and moving faster compared to control patients (63.5 percent vs. 20.7 percent), fewer ERAS patients required postoperative catheterization (40.7 percent vs 32.7 percent), and the ERAS group also had shorter hospital stays (3.4 vs. 3.9 days).

"Previous publications have demonstrated ERAS implementation in neurosurgery practices primarily through minimally invasive spinal surgery, but our neurosurgical practice has been actively applying ERAS principles to elective spine and peripheral nerve surgery since 2017, in coordination with a variety of departments across the health system," said Tracy M. Flanders, MD, first author and Neurosurgery resident at Penn. "This study captures the exciting benefits of this protocol for minimizing opioid use, decreasing length of stay, and more--without impacting patient satisfaction."

Additional Penn co-authors include Joseph Ifrach, Saurabh Sinha, Disha S. Joshi, Ali K. Ozturk, Neil R. Malhotra, Rachel Pessoa, Michael J. Kallan, Lee A. Fleisher, Michael A. Ashburn, Eileen Maloney, and William C. Welch.
-end-
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center--which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report--Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation's first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.

University of Pennsylvania School of Medicine

Related Neurosurgery Articles from Brightsurf:

Pan-microbial study implicates a potential culprit in a pediatric brain disorder in Uganda
Researchers have identified a new species of bacteria that may contribute to the dangerous buildup of brain fluid after infections in newborns, according to their analysis of 100 infants in Uganda.

Neurosurgery in Brazilian Amazon is possible
Low- and middle-income countries in remote locations with little access to care can create sustainable neurosurgical programs by recruiting and training young, local doctors, according to a Rutgers study.

A better avenue for neurosurgery to improve outcomes
Changing the route of entry for minimally invasive neurosurgery provides better outcomes for a wide range of interventions, and is preferred by patients.

Which brain hemorrhage patients have treatable underlying conditions
A new study identifies patients more likely to have underlying lesions from brain-bleeds, a finding that could help doctors treat the condition more rapidly.

Improving operations for the brain's most malignant tumor
Important research by Barrow Neurological Institute neurosurgeons and University of Washington (UW) scientists on novel imaging technology for malignant brain tumors was published in the August issue of the Nature journal, Scientific Reports.

Qual­ity re­gisters for sur­gery ex­clude many treat­ment-re­lated ad­verse events
According to a recent study, many extensive national registries are primarily based on data collected for administrative purposes, and often feature selective and incomplete reporting of treatment outcomes.

World's first intra-operative MRI-guided robot for bilateral stereotactic neurosurgery
A HKU Mechanical Engineering team led by Dr. Kwok Ka-wai recently designed the first neurosurgical robotic system capable of performing bilateral stereotactic neurosurgery inside a magnetic resonance imaging ('MRI') scanner.

Robotically controlled digital microscope provides new visualization system in operating room
The Department of Neurosurgery at the Mount Sinai Health System is one of the first hospitals in the country to use Modus V™, a hands-free, robotically controlled digital microscope that provides advanced visualization in the operating room.

Newly discovered biomarkers could be key to predicting severity of brain tumor recurrence
Researchers have identified predictive biomarkers that could help assess the level of risk for recurrence in patients with malignant glioma.

Amyloid protein transmission through neurosurgery
Amyloid beta pathology -- protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study.

Read More: Neurosurgery News and Neurosurgery Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.